CEO elaborates on global efforts to enhance early diagnosis of rare hereditary diseases and metabolomics approaches to address diverse patient populations | Dr. Arndt Rolfs, CEO, Centogene NV. 00:10:00
In this interview CEO discusses the company's focus on improving early diagnosis of rare hereditary diseases globally, emphasizing the importance of simplicity in diagnostic workflows and the integration of proteomics and metabolomics approaches to address ethnic diversity in patient populations.
